Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ditropan XL for Hot Flashes in Postmenopausal Women
NCT00990886Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of oxybutynin in hot flashes, sponsored by Janssen Pharmaceutical. Started Apr 2004; status: completed.
02
Drugs
oxybutynin
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT00990886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00990886.